stoxline Quote Chart Rank Option Currency Glossary
  
Haleon plc (HLN)
11.14  0.08 (0.72%)    05-23 16:00
Open: 11.12
High: 11.19
Volume: 20,774,140
  
Pre. Close: 11.06
Low: 11.0511
Market Cap: 50,245(M)
Technical analysis
2025-05-23 4:48:24 PM
Short term     
Mid term     
Targets 6-month :  13.06 1-year :  15.26
Resists First :  11.18 Second :  13.06
Pivot price 10.77
Supports First :  10.44 Second :  9.98
MAs MA(5) :  11.03 MA(20) :  10.66
MA(100) :  10.03 MA(250) :  9.72
MACD MACD :  0.2 Signal :  0.1
%K %D K(14,3) :  92 D(3) :  93.8
RSI RSI(14): 66
52-week High :  11.18 Low :  8.24
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ HLN ] has closed below upper band by 8.4%. Bollinger Bands are 7.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 11.2 - 11.25 11.25 - 11.29
Low: 10.93 - 10.98 10.98 - 11.03
Close: 11.04 - 11.13 11.13 - 11.21
Company Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Headline News

Fri, 23 May 2025
Learn to Evaluate (HLN) using the Charts - news.stocktradersdaily.com

Wed, 21 May 2025
Haleon PLC Executes Share Buyback to Strengthen Capital Structure - TipRanks

Tue, 20 May 2025
Haleon PLC Executes Share Buyback to Optimize Capital Structure - TipRanks

Mon, 19 May 2025
Haleon PLC Executes Share Buyback to Strengthen Market Position - TipRanks

Thu, 15 May 2025
Haleon PLC Executes Share Buyback, Adjusts Share Capital - TipRanks

Fri, 09 May 2025
Haleon (HLN) Receives Upgrade from Morgan Stanley with Increased Price Target | HLN Stock News - GuruFocus

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 4,510 (M)
Shares Float 9,020 (M)
Held by Insiders 0 (%)
Held by Institutions 11.9 (%)
Shares Short 22,720 (K)
Shares Short P.Month 23,140 (K)
Stock Financials
EPS 0.41
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.78
Profit Margin 12.8 %
Operating Margin 22.8 %
Return on Assets (ttm) 4.5 %
Return on Equity (ttm) 8.9 %
Qtrly Rev. Growth -0.4 %
Gross Profit (p.s.) 1.57
Sales Per Share 2.49
EBITDA (p.s.) 0.59
Qtrly Earnings Growth 0 %
Operating Cash Flow 2,300 (M)
Levered Free Cash Flow 2,430 (M)
Stock Valuations
PE Ratio 26.52
PEG Ratio 0
Price to Book value 6.22
Price to Sales 4.47
Price to Cash Flow 21.84
Stock Dividends
Dividend 0.11
Forward Dividend 0
Dividend Yield 1%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android